Ember LifeSciences, Inc. · CIK 2110315
Ember LifeSciences, Inc.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
Filings
2
Original notices
1
Amendments
1
Activity
Mar 3, 2026
through Aug 20, 2026
through Aug 20, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Mar 3, 2026 · D | Aug 20, 2026 · D/A | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $50,000,000 | $50,000,000 | $0 |
| Reported amount sold | $20,941,497 | $32,166,448 | $11,224,951 |
| Reported investor count | — | 50 | — |
| Reported minimum investment | $1 | $1 | $0 |
Earlier SEC source: 0002110315-26-000001 · Later SEC source: 0001814554-26-000157
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $50,000,000
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $32,166,448
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Form D filings (2)
-
0001814554-26-000157D/A · Aug 20, 2026 · Other TechnologyOffering: $50,000,000Sold: $32,166,448
Compared with 0002110315-26-000001:
- Reported amount sold: $20,941,497 → $32,166,448
- Reported investor count: Unavailable → 50
-
0002110315-26-000001D · Mar 3, 2026 · Other TechnologyOffering: $50,000,000Sold: $20,941,497